Navigation Links
VersaStep™ Plus Long Instrument with 150 mm Working Length

ProductsVersaStep™ Plus Long Instrument with 150 mm Working Length
Company Autosuture
Item VersaStep™ Plus Long Instrument with 150 mm Working Length
Features 
  • Unique endoscopic entry device
  • Applications in laparoscopic procedures
  • 150 mm working length
  • Used to establish entry into the abdominal cavity
  • 12 mm Cannula & Dilator with or without radially expandable sleeve
  • 5 mm Cannula and Dilator with radially expandable sleeve
  • Radially expandable sleeve also available separately
  • 3 units per box
  • 6 units per box (VS101500 only)
  • 12 units per box (VS150000 only)
  • Description VERSASTEP™ Plus Long Instrument for applications in laparoscopic procedures.

    The VERSASTEP™ Plus Long Instrument with 150mm Working Length is a unique endoscopic entry device that has applications in laparoscopic procedures. It is used to establish entry into the abdominal cavity.
    Info Autosuture
    Customer Service: (800) 722-8772
    Web site: http://www.autosuture.com

    Related medicine products :

    1. VersaStep™ Plus Instrument
    2. VersaStep™ Plus Short Instrument with 70 mm Working Length
    3. VersaStep™ Reposable Powershield™ (Reusable Radiolucent Cannulae - Short Length)
    4. VersaStep™ Reposable Short Single-Use Instruments
    5. VersaStep™ SHORT Reposable (Reusable Components - Short Length)
    6. VersaStep™ Reposable (Reusable Components - Standard Length)
    7. Microsurgical Instrument Tray
    8. Instrument Tray
    9. Mayo Instrument Stand
    10. Mobile Instrument Stand
    11. Ultramatic RX Master PHOROPTOR Refracting Instrument - Minus Cylinder Black
    These specialty razor blades are feather thin and very sharp. Most users have found an increased quality level in Vibratome sections with these blades.
    This is a perfect tool for retrieving free floating sections from the Vibratome bath.
    The care package includes a spare motor, fuse, Spare Fluorescent Bulb, additional Vibratome Feather Blades, Specimen Adhesive, Specimen Mounting Blocks, and a Specimen Tray.
    Vibratome Specimen Adhesive is a special formulation developed by a major adhesive manufacturer for applications such as tissue mounting. The advantage of this adhesive is that it has a strong holdi
    Medicine Products:
    (Date:11/21/2008)...alif., Nov. 21 Album Creative Stud...unches a new program offering big brand marketing ...e large, expensive ad agency process and services,... hands-on approach," says Matt Parker, Creative Di...es experience and proven brand-building techniques...
    (Date:11/21/2008)... Fla. -- A Florida State University College of Med...vered an important new layer of regulation in the ... understanding of the way cancer begins. , Wang,...the College of Medicine, said the findings will le...ould lead to the design of new drugs that kill can...
    (Date:11/21/2008)...ov. 21 The Providence Se...ed that Craig A. Norris, the Company,s,Chief Oper... Board of,Directors. Mr. Norris, appointment fil... of Steven I. Geringer and returns the board to si...ittee of the Board. , Mr. Norris, age 41, h...
    (Date:11/21/2008)...e day lead to a novel technique to combat cancer, ...thDay News) -- Belgian researchers have discovered... sugar for food, and this might lead to new treatm...vive and proliferate, all cells in the body need t...lucose], a process that requires oxygen. Compared ...
    Breaking Medicine News(10 mins):Health News:Album Creative Studios Tailors Big Brand Marketing For Small Businesses 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 2Health News:Craig A. Norris Appointed to Providence Service Corporation Board of Directors 3Health News:New Approach Keeps Tumor Cells From Refueling 2
    ...en suffer from asthma more than any other chronic ...hildren have a greater risk// than others of exper...gency. Previous research has shown that in compa..., African-Americans have a higher rate of asthma, ...
    ...chers have found that a method of natural family p...ertile phase in a woman’s menstrual// cycle is as ...nplanned pregnancies, according to a report. The ...f natural family planning (NFP) that enables coupl...
    ...ng is the primary emotion felt after the death of ...o depression being the primary// emotion and the o...arch. The researchers from the Harvard Medical S...cine came about their conclusions while interviewi...
    ...a remains a dreaded human infection with around 30...rted every year. Controlling this disease// requir...nvolves a study of its basic reproductive number, ...e average number of secondary cases infected by a ...
    Other Medicine News:Health News:Race May Play a Role in Children’s Asthma Car 2Health News:Family Planning Method is as Effective as the Contraceptive Pill 2Health News:Family Planning Method is as Effective as the Contraceptive Pill 3Health News:Family Planning Method is as Effective as the Contraceptive Pill 4Health News:Yearning -the Most Intense Emotion in Bereavement 2
    (Date:11/20/2008)...mber 20 Arpida (SWX:,AR...Advisory Committee of the,U.S. Food and Drug Admi...proval of intravenous iclaprim, an antibiotic curr...s with complicated skin and skin structure infecti...in-resistant Staphylococcus,aureus (MRSA). , ...
    (Date:11/20/2008)... -- Clinical data from a prospective,registry pre...m shows DVT,treatment with the Trellis(R) Periphe...Santa Clara, CA) successfully breaks up the blood ... This technique, called isolated pharmacomechani...y and safely than current catheter-directed thromb...
    (Date:11/19/2008)...eve statistical significance , , ISELIN, N....poration (Nasdaq: PARS ) today announced results...anoEmulsion (NE) drug delivery technology formulat...he multi-center, randomized, double-blinded, place...acy of the Company,s 3% Diclofenac Diethanolamine ...
    (Date:11/18/2008)...e-FirstCall/ -- NeuroDiscovery Ltd (ASX:,NDL), a ...evelopment Company,and Sosei Group Corporation (...rnational biopharmaceutical company, today announc...al pre-clinical efficacy data for NSL-043/SD118.,...or neuropathic pain and has,successfully complete...
    Breaking Medicine Technology:Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 2Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 3Arpida Comments on FDA's Anti-infective Drugs Advisory Committee Outcome 4Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 2Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series 3Pharmos Announces Clinical Results from Phase 2a Trial of Topical Diclofenac NanoEmulsion Cream 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 2Sosei and NeuroSolutions Present Further Data on NSL-043/SD118 at the Society for Neuroscience 38th Annual Meeting 3Nicotine Plus Alcohol May Be Tough to Beat 5651 1Nicotine Plus Alcohol May Be Tough to Beat 5651 2Nicotine Plus Alcohol May Be Tough to Beat 5651 3AIM Quoted Verona Pharma Progresses Anti Asthma Drug Studies 1705 1AIM Quoted Verona Pharma Progresses Anti Asthma Drug Studies 1705 2Pharmaceutical Companies Lead Fight Against Staph and Other Infectious Diseases 771 1Pharmaceutical Companies Lead Fight Against Staph and Other Infectious Diseases 771 2MicroActive Corporation Acquired by Linden and Edgewater 5649 1MicroActive Corporation Acquired by Linden and Edgewater 5649 2
    ...ies Presented at ECCMID/ICC, MUNICH, Germany, Apri...oday announced results from two studies showing th...l growth in vitro,when tested with a common wettin...ng the activity of oritavancin against S.,pneumoni...ovel,lipoglycopeptide antibiotic, is Targanta,s le...
    ...rBChE Suppresses Amyloid Plaque,Formation , ANNAPO...ding,biodefense company specializing in the develo...ures against chemical and,biological terrorism, an...utyrylcholinesterase (rBChE) research program were...rence on,Alzheimer,s and Parkinson,s Diseases in S...
    Other Medicine Technology:Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 2Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 3Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 4Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 5Targanta Reports Improved Ability of Oritavancin to Stop Bacteria,Growth In Vitro Compared With Other Glycopeptide Antibiotics 6Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 2Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 3Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 4Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 5Pharmathene's Recombinant Butyrylcholinesterase (rBChE) Program the,Subject of Promising New Alzheimer's Research 6